Sana Biotechnology, Inc. (SANA) Tops Q2 EPS by 2c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Brookfield prices $600M senior notes at 5.65% due 2031